Literature DB >> 9126060

Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor.

N C Fox1, A M Kennedy, R J Harvey, P L Lantos, P K Roques, J Collinge, J Hardy, M Hutton, J M Stevens, E K Warrington, M N Rossor.   

Abstract

Sixteen affected individuals are described from two families with early onset autosomal dominant familial Alzheimer's disease. A mutation at codon 139 in the presenilin 1 gene on chromosome 14 results in a methionine to valine substitution which cosegregates with the disease in these families. Onset of dementia was before the age of 50 years in all individuals. The ages at onset within each family were tightly clustered but were significantly different between the families; this difference could not be accounted for by apolipoprotein E status and suggests the existence of a further genetic factor that modifies age at disease onset. The pattern of cognitive decline was similar in both families: early memory loss (initially selective for verbal memory in some individuals) was followed soon after by loss of arithmetic skills while naming and object perception skills were relatively preserved. A speech production deficit was observed in three members of one family but not in the other. Seizures were common and usually predated by myoclonic jerks by a number of years. Serial MRIs showed progressive cortical atrophy with periventricular white matter change appearing 3-4 years into the disease. PET revealed parieto-temporal hypometabolism in all individuals scanned. The diagnosis of Alzheimer's disease was confirmed with typical histopathology in one individual from each family.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126060     DOI: 10.1093/brain/120.3.491

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  24 in total

1.  Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task.

Authors:  John M Ringman; Luis D Medina; Meredith Braskie; Yaneth Rodriguez-Agudelo; Daniel H Geschwind; Miguel A Macias-Islas; Jeffrey L Cummings; Susan Bookheimer
Journal:  Cereb Cortex       Date:  2010-08-20       Impact factor: 5.357

2.  High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.

Authors:  U Finckh; T Müller-Thomsen; U Mann; C Eggers; J Marksteiner; W Meins; G Binetti; A Alberici; C Hock; R M Nitsch; A Gal
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  Neuropsychological function in nondemented carriers of presenilin-1 mutations.

Authors:  J M Ringman; C Diaz-Olavarrieta; Y Rodriguez; M Chavez; L Fairbanks; F Paz; A Varpetian; H C Maldonado; M A Macias-Islas; J Murrell; B Ghetti; C Kawas
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

4.  Performance on MMSE sub-items and education level in presenilin-1 mutation carriers without dementia.

Authors:  John M Ringman; Yaneth Rodriguez; Claudia Diaz-Olavarrieta; Mireya Chavez; Michael Thompson; Lynn Fairbanks; Francisco Paz; Arousiak Varpetian; Hector Chaparro; Miguel Angel Macias-Islas; Jill Murrell; Bernardino Ghetti; Claudia Kawas
Journal:  Int Psychogeriatr       Date:  2007-04       Impact factor: 3.878

5.  Cortical event-related potentials in preclinical familial Alzheimer disease.

Authors:  E J Golob; J M Ringman; R Irimajiri; S Bright; B Schaffer; L D Medina; A Starr
Journal:  Neurology       Date:  2009-11-17       Impact factor: 9.910

6.  Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease.

Authors:  Meredith N Braskie; Luis D Medina; Yaneth Rodriguez-Agudelo; Daniel H Geschwind; Miguel Angel Macias-Islas; Paul M Thompson; Jeffrey L Cummings; Susan Y Bookheimer; John M Ringman
Journal:  Hum Brain Mapp       Date:  2012-07-17       Impact factor: 5.038

7.  Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network.

Authors:  John M Ringman; Li-Jung Liang; Yan Zhou; Sitaram Vangala; Edmond Teng; Sarah Kremen; David Wharton; Alison Goate; Daniel S Marcus; Martin Farlow; Bernardino Ghetti; Eric McDade; Colin L Masters; Richard P Mayeux; Martin Rossor; Stephen Salloway; Peter R Schofield; Jeffrey L Cummings; Virginia Buckles; Randall Bateman; John C Morris
Journal:  Brain       Date:  2015-02-15       Impact factor: 13.501

8.  Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's disease.

Authors:  John M Ringman; Giovanni Coppola; David Elashoff; Yaneth Rodriguez-Agudelo; Luis D Medina; Karen Gylys; Jeffrey L Cummings; Greg M Cole
Journal:  Dement Geriatr Cogn Disord       Date:  2012-02-13       Impact factor: 2.959

9.  Increased fMRI signal with age in familial Alzheimer's disease mutation carriers.

Authors:  Meredith N Braskie; Luis D Medina; Yaneth Rodriguez-Agudelo; Daniel H Geschwind; Miguel Angel Macias-Islas; Jeffrey L Cummings; Susan Y Bookheimer; John M Ringman
Journal:  Neurobiol Aging       Date:  2010-12-03       Impact factor: 4.673

10.  Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.

Authors:  Alex E Roher; Chera L Maarouf; Michael Malek-Ahmadi; Jeffrey Wilson; Tyler A Kokjohn; Ian D Daugs; Charisse M Whiteside; Walter M Kalback; Mimi P Macias; Sandra A Jacobson; Marwan N Sabbagh; Bernardino Ghetti; Thomas G Beach
Journal:  Am J Neurodegener Dis       Date:  2013-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.